(NASDAQ: FTRE) Fortrea Holdings's forecast annual revenue growth rate of 1.7% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Fortrea Holdings's revenue in 2026 is $2,723,400,000.On average, 14 Wall Street analysts forecast FTRE's revenue for 2026 to be $248,149,000,000, with the lowest FTRE revenue forecast at $235,059,000,000, and the highest FTRE revenue forecast at $257,686,000,000. On average, 14 Wall Street analysts forecast FTRE's revenue for 2027 to be $255,629,000,000, with the lowest FTRE revenue forecast at $239,827,500,000, and the highest FTRE revenue forecast at $268,064,500,000.
In 2028, FTRE is forecast to generate $268,906,000,000 in revenue, with the lowest revenue forecast at $246,746,500,000 and the highest revenue forecast at $294,431,500,000.